Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern evades antibody-mediated immunity that comes from vaccination or infection with earlier variants due to accumulation of numerous spike mutations. To understand the Omicron antigenic shift, we determined cryo-electron microscopy and x-ray crystal structures of the spike protein and the receptor-binding domain bound to the broadly neutralizing sarbecovirus monoclonal antibody (mAb) S309 (the parent mAb of sotrovimab) and to the human ACE2 receptor. We provide a blueprint for understanding the marked reduction of binding of other therapeutic mAbs that leads to dampened neutralizing activity. Remodeling of interactions between the Omicron receptor-binding domain and human ACE2 likely explains the enhanced affinity for the host receptor relative to the ancestral virus.

Highlights

  • The Omicron receptor-binding domain (RBD) and the N-terminal domain (NTD) contain 15 and 11 mutations, respectively, which lead to severe dampening of plasma neutralizing activity in previously infected or vaccinated individuals [7,8,9,10,11]

  • To provide a structural framework for the observed Omicron immune evasion and altered receptor recognition, we determined cryoEM structures of the prefusionstabilized SARS-CoV-2 Omicron S ectodomain trimer bound to S309 and S2L20 (NTD-specific monoclonal antibody (mAb)) Fab fragments

  • We evaluated the binding of clinical mAbs to the Omicron receptor-binding domain (RBD) and S ectodomain trimer using surface plasmon resonance (SPR)

Read more

Summary

Introduction

The Omicron receptor-binding domain (RBD) and the N-terminal domain (NTD) contain 15 and 11 mutations, respectively, which lead to severe dampening of plasma neutralizing activity in previously infected or vaccinated individuals [7,8,9,10,11]. To provide a structural framework for the observed Omicron immune evasion and altered receptor recognition, we determined cryoEM structures of the prefusionstabilized SARS-CoV-2 Omicron S ectodomain trimer bound to S309 and S2L20 (NTD-specific mAb) Fab fragments

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.